drugset / Trial / NCT00568295

A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee

NCT00568295

RandomizedParallel-groupDouble-blindTreatment

Summary

To compare acetaminophen (Tylenol) with rofecoxib (Viox) for the treatment of Osteoarthritis of the Knee

Timeline

Start
1999-10
Primary completion
2000-10
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1300 mg Oral
Comparator rofecoxib Small molecule 12.5 mg Oral
Comparator rofecoxib Small molecule 25 mg Oral

Indications